Minimally invasive treatment of structural heart diseases is becoming more popular as an alternative to surgery for high-risk patients. These procedures are challenging and complicated, and experience is required to perform them skillfully. HeartNavigator is designed to increase surgeons' confidence in carrying out structural heart procedures. HeartNavigator simplifies planning, measurement, device selection and choice of optimal X-ray viewing angle. It gives insight into calcification distribution in the ascending aorta, aortic valve and the left ventricle. It also provides additional live 3D imaging guidance during device placement. Royal Philips is the first to receive FDA approval for this solution.